Cargando…

Clinical outcomes and prognostic factors of cyberknife stereotactic body radiation therapy for unresectable hepatocellular carcinoma

BACKGROUND: Stereotactic body radiation therapy (SBRT) has been an emerging non-invasive treatment modality for patients with hepatocellular carcinoma (HCC) when curative treatments cannot be applied. In this study, we report our clinical experience with Cyberknife SBRT for unresectable HCC and eval...

Descripción completa

Detalles Bibliográficos
Autores principales:	Que, Jenny, Kuo, Hsing-Tao, Lin, Li-Ching, Lin, Kuei-Li, Lin, Chia-Hui, Lin, Yu-Wei, Yang, Ching-Chieh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4941022/ https://www.ncbi.nlm.nih.gov/pubmed/27405814 http://dx.doi.org/10.1186/s12885-016-2512-x

Ejemplares similares

Impact of tumor size on outcome after stereotactic body radiation therapy for inoperable hepatocellular carcinoma
por: Kuo, Hsing-Tao, et al.
Publicado: (2017)

The efficacy of stereotactic body radiation therapy on huge hepatocellular carcinoma unsuitable for other local modalities
por: Que, Jenny Y, et al.
Publicado: (2014)

Challenges of BCLC stage C hepatocellular carcinoma: Results of a single-institutional experience on stereotactic body radiation therapy
por: Que, Jenny, et al.
Publicado: (2020)

Repeated CyberKnife stereotactic body radiation therapy in hepatocellular carcinoma
por: Sun, Jing, et al.
Publicado: (2020)

Comparison of stereotactic body radiation therapy with and without sorafenib as treatment for hepatocellular carcinoma with portal vein tumor thrombosis
por: Que, Jenny, et al.
Publicado: (2020)

Effect of CyberKnife stereotactic body radiation therapy for hepatocellular carcinoma on hepatic toxicity
por: Liang, Ping, et al.
Publicado: (2016)

CyberKnife Stereotactic Body Radiation Therapy as an Effective Treatment for Hepatocellular Carcinoma Patients With Decompensated Cirrhosis
por: Sun, Jing, et al.
Publicado: (2020)

Unresectable Foramen Magnum Meningioma Treated With CyberKnife Robotic Stereotactic Radiosurgery
por: Malone, Janna, et al.
Publicado: (2020)

Cyberknife Stereotactic Body Radiation Therapy for Nonresectable Tumors of the Liver: Preliminary Results
por: Goyal, K., et al.
Publicado: (2010)

Stereotactic body radiation therapy using the CyberKnife(®) system for patients with liver metastases
por: Yuan, Zhi-Yong, et al.
Publicado: (2014)

Evaluating the optimal radiation dose for definitive chemoradiotherapy for esophageal squamous cell carcinoma: A single institution experience
por: Ke, Te-Min, et al.
Publicado: (2018)

Treating Low-Grade Myxofibrosarcoma With Stereotactic Body Radiation Therapy Using CyberKnife®
por: Mizumatsu, Shinichiro, et al.
Publicado: (2021)

Radiation-Induced Secondary Cancer Risk Assessment in Patients With Lung Cancer After Stereotactic Body Radiotherapy Using the CyberKnife M6 System With Lung-Optimized Treatment
por: Chao, Pei-Ju, et al.
Publicado: (2020)

The Early Result of Whole Pelvic Radiotherapy and Stereotactic Body Radiotherapy Boost for High-Risk Localized Prostate Cancer
por: Lin, Yu-Wei, et al.
Publicado: (2014)

Long-term survival analysis in combined transarterial embolization and stereotactic body radiation therapy versus stereotactic body radiation monotherapy for unresectable hepatocellular carcinoma >5 cm
por: Su, Ting-Shi, et al.
Publicado: (2016)

Thymic Carcinoma Treated by CyberKnife Stereotactic Body Radiotherapy
por: Harada, Yuko, et al.
Publicado: (2017)

Stereotactic Body Radiation Therapy (SBRT) for Unresectable Pancreatic Carcinoma
por: Stauder, Michael C., et al.
Publicado: (2010)

Six-Dimensional Correction of Intra-Fractional Prostate Motion with CyberKnife Stereotactic Body Radiation Therapy
por: Lei, Siyuan, et al.
Publicado: (2011)

CyberKnife Stereotactic Radiosurgery for Cholangiocarcinoma
por: Harada, Yuko, et al.
Publicado: (2017)

Dose fall-off during the treatment of thoracic spine metastasis with CyberKnife stereotactic body radiation therapy (SBRT)
por: Ju, Zhongjian, et al.
Publicado: (2020)

First Asian population study of stereotactic body radiation therapy for ventricular arrhythmias
por: Ho, Li-Ting, et al.
Publicado: (2021)

Stereotactic Body Radiotherapy Boost with the CyberKnife for Locally Advanced Cervical Cancer: Dosimetric Analysis and Potential Clinical Benefits
por: Gao, Jiaxiang, et al.
Publicado: (2022)

Dosimetric factors predicting radiation pneumonitis after CyberKnife stereotactic body radiotherapy for peripheral lung cancer
por: Nakamura, Masaki, et al.
Publicado: (2016)

Dose escalation of Stereotactic Body Radiotherapy (SBRT) for locally advanced unresectable pancreatic cancer patients with CyberKnife: protocol of a phase I study
por: Qing, Shui-Wang, et al.
Publicado: (2017)

Evaluation of contrast-enhanced ultrasonography for hepatocellular carcinoma prior to and following stereotactic body radiation therapy using the CyberKnife® system: A preliminary report
por: SHIOZAWA, KAZUE, et al.
Publicado: (2016)

Assessment of Delivery Quality Assurance for Stereotactic Radiosurgery With Cyberknife
por: Li, Jun, et al.
Publicado: (2021)

Stereotactic Body Radiation Therapy (SBRT) Combined With Chemotherapy for Unresected Pancreatic Adenocarcinoma
por: Gurka, Marie K., et al.
Publicado: (2017)

Comparison of Intrafractional Motion in Head and Neck Cancer Between Two Immobilization Methods During Stereotactic Ablative Radiation Therapy by CyberKnife
por: Kang, Chen-Lin, et al.
Publicado: (2021)

Multi-institutional application of Failure Mode and Effects Analysis (FMEA) to CyberKnife Stereotactic Body Radiation Therapy (SBRT)
por: Veronese, Ivan, et al.
Publicado: (2015)

Dosimetric impacts of endorectal balloon in CyberKnife stereotactic body radiation therapy (SBRT) for early‐stage prostate cancer
por: Xiang, Hong F., et al.
Publicado: (2017)

Dosimetric and radiobiological comparison of treatment plan between CyberKnife and EDGE in stereotactic body radiotherapy for pancreatic cancer
por: Dai, Zhi-tao, et al.
Publicado: (2021)

Combining stereotactic body radiotherapy with camrelizumab for unresectable hepatocellular carcinoma: a single-arm trial
por: Li, Jian-Xu, et al.
Publicado: (2022)

Recall radiation dermatitis by sorafenib following stereotactic body radiation therapy
por: Hsieh, Chen-Hsi, et al.
Publicado: (2014)

Noninvasive cardiac radioablation for ventricular tachycardia: dosimetric comparison between linear accelerator- and robotic CyberKnife-based radiosurgery systems
por: Wang, Ching-Yu, et al.
Publicado: (2023)

Feasibility of using stereotactic body radiation therapy for unresectable soft tissue tumors of the trunk
por: Paik, Eun Kyung, et al.
Publicado: (2018)

Biologically effective dose (BED) escalation of stereotactic body radiotherapy (SBRT) for hepatocellular carcinoma patients (≤5 cm) with CyberKnife: protocol of study
por: Sun, Jing, et al.
Publicado: (2020)

Prostate-specific antigen kinetics after primary stereotactic body radiation therapy using CyberKnife for localized prostate cancer
por: Park, Yong Hyun, et al.
Publicado: (2015)

Stereotactic Ablative Radiation Therapy for Unresectable Colorectal Oligometastases
por: Sutera, Philip, et al.
Publicado: (2018)

Intravascular Placement of Metallic Coils as Lung Tumor Markers for CyberKnife Stereotactic Radiation Therapy
por: Karaman, Kutlay, et al.
Publicado: (2015)

Comparison between supine and prone patient setup for lumbosacral spinal stereotactic body radiosurgery with CyberKnife
por: Li, Jun, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vbp4b29ala15asnfrrrq38lsfs